首页 > 最新文献

Radiology. Imaging cancer最新文献

英文 中文
Cinematic Rendering of Thymoma Causing Superior Vena Cava Syndrome. 胸腺瘤引起上腔静脉综合征的电影表现。
IF 5.6 Q1 ONCOLOGY Pub Date : 2026-01-01 DOI: 10.1148/rycan.250532
Zhendong Luo, Xinping Shen
{"title":"Cinematic Rendering of Thymoma Causing Superior Vena Cava Syndrome.","authors":"Zhendong Luo, Xinping Shen","doi":"10.1148/rycan.250532","DOIUrl":"10.1148/rycan.250532","url":null,"abstract":"","PeriodicalId":20786,"journal":{"name":"Radiology. Imaging cancer","volume":"8 1","pages":"e250532"},"PeriodicalIF":5.6,"publicationDate":"2026-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12869303/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145794677","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Zero-Shot PI-RADS Version 2.1 Scoring with ChatGPT-4 Turbo and Llama 3: Diagnostic Performance and Agreement with Abdominal Radiologists. 零射击PI-RADS版本2.1与ChatGPT-4 Turbo和Llama 3评分:诊断性能和与腹部放射科医生的协议。
IF 5.6 Q1 ONCOLOGY Pub Date : 2026-01-01 DOI: 10.1148/rycan.250119
Negar Firoozeh, Domenico Mastrodicasa, Spencer Behr, Valdair Francisco Muglia, Antonio C Westphalen

This retrospective, single-center study aimed to assess the diagnostic performance and agreement of two large language models (LLMs), ChatGPT-4 Turbo (OpenAI) and Llama 3 (Meta AI), in assigning Prostate Imaging Reporting and Data System (PI-RADS) scores to prostate MRI reports and to compare their performance with two abdominal radiologists. Structured prostate MRI reports (n = 500) obtained between January and December 2022, with original PI-RADS scores removed, were processed with LLMs using a standardized prompt to extract PI-RADS version 2.1 scores. Two abdominal radiologists independently assigned scores, with a third adjudicating discrepancies. Prostate biopsy results served as the reference standard for diagnostic performance assessment. There was high agreement between both models and radiologists: ChatGPT-4 Turbo and Llama 3 achieved 97.7% agreement (κ = 0.95), agreement between the LLM and radiologists ranged from 94.7% to 95.7% (κ = 0.89-0.91), and interradiologist agreement was 94.4% (κ = 0.88). ChatGPT-4 Turbo assigned significantly higher scores than radiologists (P < .005), while differences with Llama 3 were not statistically significant (P = .08). ChatGPT-4 Turbo and the original MRI reports achieved an area under the receiver operating characteristic curve (AUC) of 0.79 for predicting prostate cancer, and radiologists and Llama 3 achieved AUCs of 0.78 each. These results suggest that LLMs could improve prostate MRI reporting through accurate and consistent PI-RADS scoring. Keywords: Prostate, Oncology, Large Language Model Supplemental material is available for this article. © RSNA, 2025.

这项回顾性的单中心研究旨在评估两种大型语言模型(llm), ChatGPT-4 Turbo (OpenAI)和Llama 3 (Meta AI)在为前列腺MRI报告分配前列腺成像报告和数据系统(PI-RADS)评分方面的诊断性能和一致性,并将其与两位腹部放射科医生的表现进行比较。2022年1月至12月期间获得的结构化前列腺MRI报告(n = 500),原始PI-RADS评分被删除,使用LLMs处理,使用标准化提示提取PI-RADS版本2.1评分。两名腹部放射科医生独立分配分数,第三名医生裁决差异。前列腺活检结果作为诊断效能评估的参考标准。模型和放射科医生之间的一致性很高:ChatGPT-4 Turbo和Llama 3达到97.7%的一致性(κ = 0.95), LLM和放射科医生之间的一致性范围为94.7%至95.7% (κ = 0.89-0.91),放射科医生之间的一致性为94.4% (κ = 0.88)。ChatGPT-4 Turbo评分明显高于放射科医师(P < 0.005),而与Llama 3的差异无统计学意义(P = 0.08)。ChatGPT-4 Turbo和原始MRI报告预测前列腺癌的受试者工作特征曲线下面积(AUC)为0.79,放射科医生和Llama 3的AUC均为0.78。这些结果表明LLMs可以通过准确一致的PI-RADS评分改善前列腺MRI报告。关键词:前列腺,肿瘤学,大语言模型本文有补充材料。©rsna, 2025。
{"title":"Zero-Shot PI-RADS Version 2.1 Scoring with ChatGPT-4 Turbo and Llama 3: Diagnostic Performance and Agreement with Abdominal Radiologists.","authors":"Negar Firoozeh, Domenico Mastrodicasa, Spencer Behr, Valdair Francisco Muglia, Antonio C Westphalen","doi":"10.1148/rycan.250119","DOIUrl":"10.1148/rycan.250119","url":null,"abstract":"<p><p>This retrospective, single-center study aimed to assess the diagnostic performance and agreement of two large language models (LLMs), ChatGPT-4 Turbo (OpenAI) and Llama 3 (Meta AI), in assigning Prostate Imaging Reporting and Data System (PI-RADS) scores to prostate MRI reports and to compare their performance with two abdominal radiologists. Structured prostate MRI reports (<i>n</i> = 500) obtained between January and December 2022, with original PI-RADS scores removed, were processed with LLMs using a standardized prompt to extract PI-RADS version 2.1 scores. Two abdominal radiologists independently assigned scores, with a third adjudicating discrepancies. Prostate biopsy results served as the reference standard for diagnostic performance assessment. There was high agreement between both models and radiologists: ChatGPT-4 Turbo and Llama 3 achieved 97.7% agreement (κ = 0.95), agreement between the LLM and radiologists ranged from 94.7% to 95.7% (κ = 0.89-0.91), and interradiologist agreement was 94.4% (κ = 0.88). ChatGPT-4 Turbo assigned significantly higher scores than radiologists (<i>P</i> < .005), while differences with Llama 3 were not statistically significant (<i>P</i> = .08). ChatGPT-4 Turbo and the original MRI reports achieved an area under the receiver operating characteristic curve (AUC) of 0.79 for predicting prostate cancer, and radiologists and Llama 3 achieved AUCs of 0.78 each. These results suggest that LLMs could improve prostate MRI reporting through accurate and consistent PI-RADS scoring. <b>Keywords:</b> Prostate, Oncology, Large Language Model <i>Supplemental material is available for this article.</i> © RSNA, 2025.</p>","PeriodicalId":20786,"journal":{"name":"Radiology. Imaging cancer","volume":"8 1","pages":"e250119"},"PeriodicalIF":5.6,"publicationDate":"2026-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12862468/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145678351","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
CT-derived Body Composition Radiomics to Predict Early Recurrence in Intrahepatic Cholangiocarcinoma. ct衍生体成分放射组学预测肝内胆管癌早期复发。
IF 5.6 Q1 ONCOLOGY Pub Date : 2026-01-01 DOI: 10.1148/rycan.259039
Yashbir Singh
{"title":"CT-derived Body Composition Radiomics to Predict Early Recurrence in Intrahepatic Cholangiocarcinoma.","authors":"Yashbir Singh","doi":"10.1148/rycan.259039","DOIUrl":"10.1148/rycan.259039","url":null,"abstract":"","PeriodicalId":20786,"journal":{"name":"Radiology. Imaging cancer","volume":"8 1","pages":"e259039"},"PeriodicalIF":5.6,"publicationDate":"2026-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12862460/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145893211","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Synergistic Breakthroughs in Quantitative Neuro-oncologic MRI-toward a Stable and Comprehensive Clinical Tool. 神经肿瘤定量mri的协同突破,迈向稳定和全面的临床工具。
IF 5.6 Q1 ONCOLOGY Pub Date : 2025-11-01 DOI: 10.1148/rycan.250534
Yifang Bao, Yuxin Li
{"title":"Synergistic Breakthroughs in Quantitative Neuro-oncologic MRI-toward a Stable and Comprehensive Clinical Tool.","authors":"Yifang Bao, Yuxin Li","doi":"10.1148/rycan.250534","DOIUrl":"10.1148/rycan.250534","url":null,"abstract":"","PeriodicalId":20786,"journal":{"name":"Radiology. Imaging cancer","volume":"7 6","pages":"e250534"},"PeriodicalIF":5.6,"publicationDate":"2025-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12670038/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145459605","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The SCARLET Trial: Radiotheranostics in Multiple Myeloma. SCARLET试验:多发性骨髓瘤的放射治疗。
IF 5.6 Q1 ONCOLOGY Pub Date : 2025-11-01 DOI: 10.1148/rycan.259036
Sanchay Jain, Michael M Graham
{"title":"The SCARLET Trial: Radiotheranostics in Multiple Myeloma.","authors":"Sanchay Jain, Michael M Graham","doi":"10.1148/rycan.259036","DOIUrl":"10.1148/rycan.259036","url":null,"abstract":"","PeriodicalId":20786,"journal":{"name":"Radiology. Imaging cancer","volume":"7 6","pages":"e259036"},"PeriodicalIF":5.6,"publicationDate":"2025-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12670027/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145565237","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Monitoring Triple-Negative Breast Cancer with a Trop2-targeted Peptide PET Probe. 用trop2靶向肽PET探针监测三阴性乳腺癌。
IF 5.6 Q1 ONCOLOGY Pub Date : 2025-11-01 DOI: 10.1148/rycan.259035
Barish H Edil, Happy Agarwal, Muthuvel Panneerselvam, Lacey R McNally
{"title":"Monitoring Triple-Negative Breast Cancer with a Trop2-targeted Peptide PET Probe.","authors":"Barish H Edil, Happy Agarwal, Muthuvel Panneerselvam, Lacey R McNally","doi":"10.1148/rycan.259035","DOIUrl":"10.1148/rycan.259035","url":null,"abstract":"","PeriodicalId":20786,"journal":{"name":"Radiology. Imaging cancer","volume":"7 6","pages":"e259035"},"PeriodicalIF":5.6,"publicationDate":"2025-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12670014/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145565145","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Sociodemographic Predictors of County-Level Mammography Screening Rates in the United States. 美国县级乳房x光检查率的社会人口学预测因素。
IF 5.6 Q1 ONCOLOGY Pub Date : 2025-11-01 DOI: 10.1148/rycan.240433
Randy C Miles, Caroline J Walsh, Nhat-Tuan Tran, Joanna Garcia, Brandon O'Connor, Anand K Narayan, Antonio R Porras

Purpose To evaluate predictors of mammography engagement at the county level to better understand the challenges associated with population-based screening in the United States. Materials and Methods This retrospective, geospatial, cross-sectional study conducted from March 2024 to September 2024 used data from the 2023 National Cancer Institute's Small Area Estimates, County Health Rankings, and the Atlas of Rural and Small-Town America. Univariable linear regression analyses were conducted to evaluate the relationship between sociodemographic variables and county-level mammography screening rates. Multivariable linear regression was performed to create an average model of mammography screening rates as a function of county-level sociodemographic variables, which was then used to assess county screening performance after adjusting for these factors. Results Information obtained from 3121 counties was included in this study. Higher percentages of White residents, residents older than 18 years, women, rural residents, and high school graduates were positively associated with county-level screening rates, while higher percentages of non-Black minority residents, residents with limited English proficiency, and uninsured residents were negatively associated with county-level mammography screening rates (P < .001). After accounting for sociodemographic composition, counties with a higher proportion of Black residents (P < .001), residents with limited English proficiency (P = .009), insured residents (P < .001), high school graduates (P < .001), and residents with higher median income (P < .001) exceeded expected screening rates based on national county-level data. Conclusion In this national county-level model, population-based characteristics associated with mammography engagement at the county level could be used to estimate expected screening rates based on each county's sociodemographic profile. Keywords: Mammography, Breast, Screening, Socioeconomic Issues, Oncology, Epidemiology, Statistics, Health Policy and Practice ©RSNA, 2025.

目的评估县一级乳房x光检查参与的预测因素,以更好地了解美国基于人群的筛查所面临的挑战。材料和方法这项回顾性、地理空间、横断面研究于2024年3月至2024年9月进行,使用的数据来自2023年国家癌症研究所的小区域估计、县健康排名以及美国农村和小城镇地图集。采用单变量线性回归分析评估社会人口学变量与县级乳房x光筛查率之间的关系。采用多变量线性回归建立了乳房x光检查筛查率作为县级社会人口变量函数的平均模型,然后在调整这些因素后用于评估县级筛查绩效。结果本研究纳入了来自3121个县的信息。较高百分比的白人居民、18岁以上居民、妇女、农村居民和高中毕业生与县级乳房x光检查率呈正相关,而较高百分比的非黑人少数民族居民、英语水平有限的居民和未投保居民与县级乳房x光检查率呈负相关(P < .001)。在考虑了社会人口构成因素后,黑人居民比例较高(P < 0.001)、英语水平有限的居民(P = 0.009)、有保险的居民(P < 0.001)、高中毕业生(P < 0.001)和收入中位数较高的居民(P < 0.001)的县超出了基于全国县级数据的预期筛查率。结论:在这个国家县级模型中,基于人口的特征与县级乳房x光检查参与相关,可以用来估计基于每个县的社会人口特征的预期筛查率。关键词:乳房x线摄影,乳房,筛查,社会经济问题,肿瘤学,流行病学,统计学,卫生政策与实践©RSNA, 2025。
{"title":"Sociodemographic Predictors of County-Level Mammography Screening Rates in the United States.","authors":"Randy C Miles, Caroline J Walsh, Nhat-Tuan Tran, Joanna Garcia, Brandon O'Connor, Anand K Narayan, Antonio R Porras","doi":"10.1148/rycan.240433","DOIUrl":"10.1148/rycan.240433","url":null,"abstract":"<p><p>Purpose To evaluate predictors of mammography engagement at the county level to better understand the challenges associated with population-based screening in the United States. Materials and Methods This retrospective, geospatial, cross-sectional study conducted from March 2024 to September 2024 used data from the 2023 National Cancer Institute's Small Area Estimates, County Health Rankings, and the Atlas of Rural and Small-Town America. Univariable linear regression analyses were conducted to evaluate the relationship between sociodemographic variables and county-level mammography screening rates. Multivariable linear regression was performed to create an average model of mammography screening rates as a function of county-level sociodemographic variables, which was then used to assess county screening performance after adjusting for these factors. Results Information obtained from 3121 counties was included in this study. Higher percentages of White residents, residents older than 18 years, women, rural residents, and high school graduates were positively associated with county-level screening rates, while higher percentages of non-Black minority residents, residents with limited English proficiency, and uninsured residents were negatively associated with county-level mammography screening rates (<i>P</i> < .001). After accounting for sociodemographic composition, counties with a higher proportion of Black residents (<i>P</i> < .001), residents with limited English proficiency (<i>P</i> = .009), insured residents (<i>P</i> < .001), high school graduates (<i>P</i> < .001), and residents with higher median income (<i>P</i> < .001) exceeded expected screening rates based on national county-level data. Conclusion In this national county-level model, population-based characteristics associated with mammography engagement at the county level could be used to estimate expected screening rates based on each county's sociodemographic profile. <b>Keywords:</b> Mammography, Breast, Screening, Socioeconomic Issues, Oncology, Epidemiology, Statistics, Health Policy and Practice ©RSNA, 2025.</p>","PeriodicalId":20786,"journal":{"name":"Radiology. Imaging cancer","volume":"7 6","pages":"e240433"},"PeriodicalIF":5.6,"publicationDate":"2025-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12670021/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145355831","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Safety and Efficacy of Thermal Ablation for Benign Thyroid Nodules in Patients with or without Previous Thyroid Surgery. 热消融治疗甲状腺良性结节的安全性和有效性:有或没有甲状腺手术史的患者。
IF 5.6 Q1 ONCOLOGY Pub Date : 2025-11-01 DOI: 10.1148/rycan.240431
Meng-Yu Lu, Wen-Wen Yue, Jia-Xin Li, Jing-E Zhu, Xiao-Wan Bo, Hui-Li Zhang, Yin-Cheng Gao, Guan-Qun Zhang, Hao-Jie Yang, Li-Ping Sun

Purpose To examine the use of propensity score matching (PSM) to compare the safety and efficacy of US-guided thermal ablation (TA) as a first-line treatment for initial thyroid nodules versus as a second-line treatment for recurrent nodules following thyroid surgery. Materials and Methods This retrospective study included data from 693 patients with benign thyroid nodules (BTNs) who underwent US-guided TA between January 2015 and July 2023. These included 619 patients in the initial nodule group and 74 patients in the recurrent nodule group. PSM was employed to balance preablation data and minimize confounding bias between the two groups. The perioperative and post-TA complication rates of the two matched patient groups were compared. Nodule volume and volume reduction rate (VRR) were compared at 1, 3, 6, and 12 months after TA. Thyroid function, symptoms, and cosmetic scores were also compared. Results Successful matching of 222 patients (mean age ± SD, 55.92 years ± 12.08; 172 female) (2:1 ratio) was achieved, with 148 patients in the initial nodule group and 74 patients in the recurrent nodule group. There was no evidence of a difference between the two groups regarding incidence of major complications (P > .99), minor complications (P = .82), or adverse effects (P = .51). The difference in VRR between the two groups at each follow-up point was not statistically significant (P = .30, .28, .33, .20, .33, respectively). At the last follow-up, symptom and cosmetic scores were significantly reduced in both groups (both P < .01), whereas serum thyroid hormone levels were not significantly different from those before TA treatment (all P > .05). Conclusion US-guided TA treatment exhibited a favorable safety and efficacy profile for patients with BTNs, regardless of prior thyroid surgery. Supplemental material is available for this article. © RSNA, 2025 Keywords: Head/Neck, Thyroid, Treatment Effects, Efficacy Studies, Ablation Techniques (Radiofrequency, Thermal, Chemical).

目的研究使用倾向评分匹配(PSM)来比较美国引导的热消融(TA)作为初始甲状腺结节的一线治疗与甲状腺手术后复发性结节的二线治疗的安全性和有效性。材料和方法本回顾性研究纳入了2015年1月至2023年7月期间693例接受US-guided TA治疗的良性甲状腺结节(BTNs)患者的数据。其中初始结节组619例,复发结节组74例。PSM用于平衡消融前数据,减少两组间的混杂偏倚。比较两组患者围手术期及术后并发症发生率。比较TA术后1、3、6、12个月的结节体积和体积缩小率(VRR)。甲状腺功能、症状和美容评分也进行了比较。结果222例患者(平均年龄±SD, 55.92岁±12.08岁,女性172例)匹配成功(比例为2:1),其中初发结节组148例,复发结节组74例。两组在主要并发症(P = 0.99)、次要并发症(P = 0.82)或不良反应(P = 0.51)发生率方面无差异。两组在各随访点的VRR差异无统计学意义(P = 0.30, P < 0.05)。28日。33岁。20.。分别为33)。末次随访时,两组患者的症状和美容评分均显著降低(P均< 0.01),血清甲状腺激素水平与TA治疗前比较差异无统计学意义(P均< 0.05)。结论:无论是否有甲状腺手术史,美国引导下的TA治疗对BTNs患者具有良好的安全性和有效性。本文有补充材料。©RSNA, 2025关键词:头颈部,甲状腺,治疗效果,疗效研究,消融技术(射频,热,化学)。
{"title":"Safety and Efficacy of Thermal Ablation for Benign Thyroid Nodules in Patients with or without Previous Thyroid Surgery.","authors":"Meng-Yu Lu, Wen-Wen Yue, Jia-Xin Li, Jing-E Zhu, Xiao-Wan Bo, Hui-Li Zhang, Yin-Cheng Gao, Guan-Qun Zhang, Hao-Jie Yang, Li-Ping Sun","doi":"10.1148/rycan.240431","DOIUrl":"10.1148/rycan.240431","url":null,"abstract":"<p><p>Purpose To examine the use of propensity score matching (PSM) to compare the safety and efficacy of US-guided thermal ablation (TA) as a first-line treatment for initial thyroid nodules versus as a second-line treatment for recurrent nodules following thyroid surgery. Materials and Methods This retrospective study included data from 693 patients with benign thyroid nodules (BTNs) who underwent US-guided TA between January 2015 and July 2023. These included 619 patients in the initial nodule group and 74 patients in the recurrent nodule group. PSM was employed to balance preablation data and minimize confounding bias between the two groups. The perioperative and post-TA complication rates of the two matched patient groups were compared. Nodule volume and volume reduction rate (VRR) were compared at 1, 3, 6, and 12 months after TA. Thyroid function, symptoms, and cosmetic scores were also compared. Results Successful matching of 222 patients (mean age ± SD, 55.92 years ± 12.08; 172 female) (2:1 ratio) was achieved, with 148 patients in the initial nodule group and 74 patients in the recurrent nodule group. There was no evidence of a difference between the two groups regarding incidence of major complications (<i>P</i> > .99), minor complications (<i>P</i> = .82), or adverse effects (<i>P</i> = .51). The difference in VRR between the two groups at each follow-up point was not statistically significant (<i>P</i> = .30, .28, .33, .20, .33, respectively). At the last follow-up, symptom and cosmetic scores were significantly reduced in both groups (both <i>P</i> < .01), whereas serum thyroid hormone levels were not significantly different from those before TA treatment (all <i>P</i> > .05). Conclusion US-guided TA treatment exhibited a favorable safety and efficacy profile for patients with BTNs, regardless of prior thyroid surgery. <i>Supplemental material is available for this article.</i> © RSNA, 2025 <b>Keywords:</b> Head/Neck, Thyroid, Treatment Effects, Efficacy Studies, Ablation Techniques (Radiofrequency, Thermal, Chemical).</p>","PeriodicalId":20786,"journal":{"name":"Radiology. Imaging cancer","volume":"7 6","pages":"e240431"},"PeriodicalIF":5.6,"publicationDate":"2025-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12670015/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145213427","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Persistent Disparities Across Age, Race, and Ethnicity Revealed in Recent Report on U.S. Breast Cancer Mortality Trends. 最近的美国乳腺癌死亡率趋势报告揭示了年龄、种族和民族之间的持续差异。
IF 5.6 Q1 ONCOLOGY Pub Date : 2025-11-01 DOI: 10.1148/rycan.259032
Semira Sherief, Tatiana Kelil
{"title":"Persistent Disparities Across Age, Race, and Ethnicity Revealed in Recent Report on U.S. Breast Cancer Mortality Trends.","authors":"Semira Sherief, Tatiana Kelil","doi":"10.1148/rycan.259032","DOIUrl":"10.1148/rycan.259032","url":null,"abstract":"","PeriodicalId":20786,"journal":{"name":"Radiology. Imaging cancer","volume":"7 6","pages":"e259032"},"PeriodicalIF":5.6,"publicationDate":"2025-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12670010/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145565232","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
PSMA PET-guided Intensification of Salvage Radiotherapy after Radical Prostatectomy. PSMA pet引导下前列腺根治术后补救性放疗强化。
IF 5.6 Q1 ONCOLOGY Pub Date : 2025-11-01 DOI: 10.1148/rycan.259038
Ridvan A Demirci, Amir Iravani
{"title":"PSMA PET-guided Intensification of Salvage Radiotherapy after Radical Prostatectomy.","authors":"Ridvan A Demirci, Amir Iravani","doi":"10.1148/rycan.259038","DOIUrl":"10.1148/rycan.259038","url":null,"abstract":"","PeriodicalId":20786,"journal":{"name":"Radiology. Imaging cancer","volume":"7 6","pages":"e259038"},"PeriodicalIF":5.6,"publicationDate":"2025-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12670011/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145638018","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Radiology. Imaging cancer
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1